Drugs in Clinical Development Overview
PharmaNet/i3, a leader in drug development services, has a global infrastructure, therapeutic expertise, and commitment to quality that is unmatched in the industry. For pharmaceutical, biotechnology, generic drug, and medical device companies of all sizes around the world, PharmaNet/i3 works for you.
PharmaNet/i3 can conduct your Phase I – IIa clinical trials, quickly and efficiently in healthy and special populations. Our extensive database ensures rapid study participant recruitment and collaborations with world leading hospitals and research h centers allows us to access to special populations to meet the needs of your program, from proof of concept and first in man, cardiac safety, to drug interaction and study.
For Phase IIb – III clinical trials we offer a full range of services including biostatistics, data management, project management, study monitoring, patient recruitment, and global safety and pharmacovigilance. Our expertise in oncology, cardiology, neuroscience, infectious disease, and other therapeutic areas ensure that our project team professionally executes your program. Our exclusive access to UnitedHealth Care claims data allows you to have real-time, robust insight into the right patient populations and investigators. We will then consult with you to apply the data and develop a protocol for an efficient, safe and cost effective study.
Following approval, PharmaNet/i3 Phase IV experts can guide you through the design and execution of a post-approval program, while addressing the needs and concerns of patients, providers, payers, and government regulators. We offer the vision and clarity to help you make smart and profitable decisions for your post-marketing programs with services including strategic and operational planning, observational studies and patient registries, health economics and outcomes research, safety/risk management and epidemiology, traditional interventional studies.
If you are looking for one to one thousand clinical research professionals, we have resourcing and staffing solutions to fit your requirements. Unique strategic partnership experience allows us to create the right team for your business goals. A customer-focused team can handle a single function across several drug programs, a range of functions within a single therapeutic area, a complete staff lift-out or any other defined need—serving as a consistent, scalable resource. We currently have 32 active partnerships dating back to 1999.
Whether you need a single clinical project manager or an experienced team to complete a study, we can find you the right clinical development professionals, when you need them. PharmaNet/i3 Strategic Resourcing is powered by the capabilities of i3 Pharma Resourcing, MedFocus, Smith Hanley, PharmaNet Resource Solutions and KCR and more than 40 years of combined experience and success in the field. Our staffing and business process outsourcing solutions are simply unmatched.
During your study, high quality and timely bioanalytical results are critical. PharmaNet/i3 scientists have the expertise to solve the most complex bioanalytical problems, for small or large molecules, by developing and validating methods and using techniques from GC, GC/MS/MS, and LC/MS/MS to ELISAs, RIAs, immunoassays, and biomarkers. See our list of more than 1000 assays.
From preclinical to post-approval, we provide superior service to clients for both regulatory strategies and processes. We have assembled an exceptional team of former senior-level FDA officials, as well as other international regulatory and pharmaceutical consultants experienced in clinical development, planning and execution, and regulatory submissions.
For the applied knowledge, intelligent solutions, and a clinical development partner that you can trust, PharmaNet/i3 works for you.
